Data capture is no longer the bottleneck, and whether the lag between a signal and a decision shrinks depends on signal design, AI governance, and vendor orchestration.
|Webcasts|July 14, 2021
Patient Centricity by Design – Improving patient engagement and retention while reducing burden with fit-for-purpose technology
Author(s)IQVIA
Wednesday, July 14, 2021 at 11am EDT Looking for tested strategies to design and deliver truly patient-centric clinical trials? Join IQVIA experts for an insightful webinar on “Patient Centricity by Design: Improving patient engagement and retention while reducing burden with fit-for-purpose technology,” where you’ll hear how to enhance recruitment, strengthen patient and site relationships and deliver faster access through intelligent connections and decentralized trials approaches.
Register Now:
Event Overview:
Patients are savvier and more engaged than ever before in their healthcare. As the industry strives to deliver more site-centric, patient focused clinical trials, a designed thinking approach can help sponsors more purposefully select and deploy innovative solutions that enhance patients’ experience and deliver faster, higher quality clinical trials.
Join this webinar to learn ways to put patient-centricity to practice – from pre-trial surveys to connected devices and decentralized clinical trial models – and why trials designed around the patient expands clinical trial access, reduces burden, and improve usability. Learn how IQVIA is making intelligent connections across healthcare data, patient recruitment and enablement, decentralized trials and connected devices to deliver on our industry’s patient centricity promise.
3 Key take-aways:
As you look to overcome complexity, accelerate timelines and maximize efficiencies in your clinical trials, join this timely webinar to learn how to:
- Deliver on the demand for faster, patient-focused trials by giving patients more control over their trial experience
- Accelerate seamless data collection while reducing patient burden of trial participation by purposefully deploying connected devices
- Design decentralized trials based on patients’ daily lives, preferences and needs in mind
Speakers
Mark Mentzer, Director, Large Pharma, IQVIA Connected Devices
Kelly Sanford, MSHS, PMP, CCRA
Global Head of Site Operations
IQVIA Decentralized Trials Solutions
Katie Shaw
Senior Director, Patient Recruitment & Enablement
IQVIA
Sponsor:
IQVIA
Register Now:
Related to this article
In this Q&A, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, discusses what changes when AI is embedded across protocol strategy, data infrastructure, and workflow tools at once, where governance frameworks tend to fall short, and why CROs must orchestrate AI ecosystems rather than simply aggregate them.
In today’s ACT Brief, we examine what policy changes would help community and rural institutions join research, how Walmart is expanding clinical trial centers into three more states, and how FDA approved Ilumya for adults with active psoriatic arthritis.
The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health screenings inside Walmart stores.
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
In today’s ACT Brief, we examine why community and rural patients lack access to research as a care option, what makes AI assistants trustworthy in regulated trials, and how FDA draft guidance could let gene editing therapies cover patient-specific variants.
In this Q&A, E.K. Koh, chief product officer at Suvoda, discusses what separates a trustworthy AI assistant from one that adds risk, why curated clinical knowledge matters more than general-purpose flexibility, and what safeguards must be in place when assistants move from answering questions to taking actions in clinical trial systems.
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patients in community and rural settings too often lack access to clinical research as a care option, and how closing that gap could improve outcomes and lower long-term costs.
Trending on Applied Clinical Trials Online
1
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
2
What Needs to Happen Beyond the Clinical Trial Modernization Act
3
From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions
4
Walmart and Care Access Plan Three More Clinical Trial Centers in Michigan, Nevada, and Texas
5